Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05843500 · ClinicalTrials.gov registry record
Chronic Thromboembolic Disease Registry
A clinical trial of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05843500: Recruiting study of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease, sponsored by University of California, San Francisco.
NCT05843500 is a study of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 767-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05843500, a study of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including medication, balloon pulmonary angioplasty, and pulmonary endarterectomy * Effect of treatment on patient's quality of life and exercise tolerance Participants will be followed longitudinally to assess their health outcomes and quality of life via chart review and health quality surveys.
Primary Outcome
The total number of patients who are alive
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2028-07-01 |
What NCT05843500 shows while recruiting
NCT05843500 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 767-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Chronic Thromboembolic Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT05843500 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05843500 about?
NCT05843500 is a clinical study titled "Chronic Thromboembolic Disease Registry". The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including m...
What is the current status of trial NCT05843500?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-08-01. Estimated completion is 2028-07-01.
What conditions does trial NCT05843500 study?
This clinical trial studies the following conditions: Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Disease.
What interventions are being tested in trial NCT05843500?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05843500?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05843500 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Thromboembolic Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Pulmonary Hypertension Biorepository and Registry
RECRUITING
-
Pulmonary Hypertension Association Registry
RECRUITING
-
TrEatment Approach in the Multimodal Era Registry
ACTIVE NOT RECRUITING
-
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI